These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33263170)

  • 1. Oral high-dose sucrosomial iron vs intravenous iron in sideropenic anemia patients intolerant/refractory to iron sulfate: a multicentric randomized study.
    Giordano G; Napolitano M; Di Battista V; Lucchesi A
    Ann Hematol; 2021 Sep; 100(9):2173-2179. PubMed ID: 33263170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Sucrosomial® iron versus intravenous iron for recovering iron deficiency anaemia in ND-CKD patients: a cost- minimization analysis.
    Riccio E; Sabbatini M; Capuano I; Pellegrino AM; Petruzzelli LA; Pisani A
    BMC Nephrol; 2020 Feb; 21(1):57. PubMed ID: 32087684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Randomized Noninferiority Trial of Intravenous Iron Isomaltoside versus Oral Iron Sulfate in Patients with Nonmyeloid Malignancies and Anemia Receiving Chemotherapy: The PROFOUND Trial.
    Birgegård G; Henry D; Glaspy J; Chopra R; Thomsen LL; Auerbach M
    Pharmacotherapy; 2016 Apr; 36(4):402-14. PubMed ID: 26927900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Costs of the treatment of iron-deficiency anemia].
    Castro Pazos M; Juncal Fondevila AR; López García B; Oujo Pujales J
    Aten Primaria; 1996 Apr; 17(7):480-2. PubMed ID: 8679883
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous iron sucrose complex in the treatment of iron deficiency anemia during pregnancy.
    al-Momen AK; al-Meshari A; al-Nuaim L; Saddique A; Abotalib Z; Khashogji T; Abbas M
    Eur J Obstet Gynecol Reprod Biol; 1996 Nov; 69(2):121-4. PubMed ID: 8902444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral Sucrosomial Iron Is as Effective as Intravenous Ferric Carboxy-Maltose in Treating Anemia in Patients with Ulcerative Colitis.
    Bertani L; Tricò D; Zanzi F; Baiano Svizzero G; Coppini F; de Bortoli N; Bellini M; Antonioli L; Blandizzi C; Marchi S
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33673371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the Therapeutic Effects and Side Effects of Oral Iron Supplements in Iron Deficiency Anemia.
    Wu TW; Tsai FP
    Drug Res (Stuttg); 2016 May; 66(5):257-61. PubMed ID: 26697889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferric Maltol: A New Oral Iron Formulation for the Treatment of Iron Deficiency in Adults.
    Khoury A; Pagan KA; Farland MZ
    Ann Pharmacother; 2021 Feb; 55(2):222-229. PubMed ID: 32633548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Financial impact of intravenous iron treatments on the management of anaemia inpatients: a 1 year observational study.
    Delpeuch A; Ruivard M; Abergel A; Aumaitre O; Boisgard S; Bagel S; Sautou V
    Int J Clin Pharm; 2018 Jun; 40(3):686-692. PubMed ID: 29520555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial.
    Van Wyck DB; Mangione A; Morrison J; Hadley PE; Jehle JA; Goodnough LT
    Transfusion; 2009 Dec; 49(12):2719-28. PubMed ID: 19682342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sucrosomial
    Asperti M; Gryzik M; Brilli E; Castagna A; Corbella M; Gottardo R; Girelli D; Tarantino G; Arosio P; Poli M
    Nutrients; 2018 Sep; 10(10):. PubMed ID: 30241424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron hydroxide polymaltose: iatrogenic cause of persistent iron deficiency anaemia despite continuous oral iron therapy.
    Mehta BC
    J Assoc Physicians India; 2002 Feb; 50():279-80. PubMed ID: 12038667
    [No Abstract]   [Full Text] [Related]  

  • 13. Optimal Serum Ferritin Levels for Iron Deficiency Anemia during Oral Iron Therapy (OIT) in Japanese Hemodialysis Patients with Minor Inflammation and Benefit of Intravenous Iron Therapy for OIT-Nonresponders.
    Takasawa K; Takaeda C; Wada T; Ueda N
    Nutrients; 2018 Mar; 10(4):. PubMed ID: 29596361
    [No Abstract]   [Full Text] [Related]  

  • 14. Randomized clinical trial of preoperative oral versus intravenous iron in anaemic patients with colorectal cancer.
    Keeler BD; Simpson JA; Ng O; Padmanabhan H; Brookes MJ; Acheson AG;
    Br J Surg; 2017 Feb; 104(3):214-221. PubMed ID: 28092401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A patient-level cost-effectiveness analysis of iron isomaltoside versus ferric carboxymaltose for the treatment of iron deficiency anemia in the United Kingdom.
    Pollock RF; Muduma G
    J Med Econ; 2020 Jul; 23(7):751-759. PubMed ID: 32208038
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravenous iron sucrose v/s oral ferrous fumarate for treatment of anemia in pregnancy. A randomized controlled trial.
    Bhavi SB; Jaju PB
    BMC Pregnancy Childbirth; 2017 May; 17(1):137. PubMed ID: 28482869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Oral Iron Therapies for Iron Deficiency Anemia in Chronic Kidney Disease.
    Pergola PE; Fishbane S; Ganz T
    Adv Chronic Kidney Dis; 2019 Jul; 26(4):272-291. PubMed ID: 31477258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous iron sucrose versus oral iron ferrous sulfate for antenatal and postpartum iron deficiency anemia: a randomized trial.
    Froessler B; Cocchiaro C; Saadat-Gilani K; Hodyl N; Dekker G
    J Matern Fetal Neonatal Med; 2013 May; 26(7):654-9. PubMed ID: 23130909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Budget Impact Analysis of Oral Fisiogen Ferro Forte
    Darbà J; Ascanio M
    Clin Drug Investig; 2018 Sep; 38(9):801-811. PubMed ID: 29934762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral sucrosomial iron versus intravenous iron in anemic cancer patients without iron deficiency receiving darbepoetin alfa: a pilot study.
    Mafodda A; Giuffrida D; Prestifilippo A; Azzarello D; Giannicola R; Mare M; Maisano R
    Support Care Cancer; 2017 Sep; 25(9):2779-2786. PubMed ID: 28391437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.